"/> Invitrogen™ Peptide synthétique LXR alpha (aa 432… | B-LABO France

Invitrogen™ Peptide synthétique LXR alpha (aa 432-442) humain

Réf. : BL-RE-175634Réf. fabricant : 11524770 50 μg
190,00 € HT

Synthetic Peptide

Gene ID (Entrez)
10062
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q13133
Nom usuel
Human LXR alpha (aa 432-442)
Marque
Invitrogen

Human LXR Alpha (residues 432-442) Synthetic Peptide, PEP-115, from Invitrogen.

NR1H3 (oxysterols receptor LXR-alpha) is a nuclear receptor that exhibits a ligand-dependent transcriptional activation activity. Its interaction with retinoic acid receptor (RXR) shifts RXR from its role as a silent DNA-binding partner to an active ligand-binding subunit in mediating retinoid responses through target genes defined by LXRES. LXRES are DR4-type response elements characterized by direct repeats of two similar hexanucleotide half-sites spaced by four nucleotides. NR1H3 plays an important role in the regulation of cholesterol homeostasis, regulating cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR, and LRP8. It also interplays functionally with RORA for the regulation of genes involves in liver metabolism.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175634
Réf. fabricant11524770
Gene ID (Entrez)10062
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ13133
Nom usuelHuman LXR alpha (aa 432-442)
Concentration0.5 mg/mL
Contenu et stockage-20°C. Avoid freeze-thaw cycles.
FormatLyophilized
Formulepeptide with no preservative
À utiliser avec (application)Control
Symbole de gène(s)NR1H3
LyophiliséLyophilized
ConservateurNo preservative
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
SéquenceC-L432-R-L-Q-D-K-K-L-P-P-L-L-S-E445
Une question, une configuration particulière ?
Contactez-nous pour un devis.